| Primary information |
|---|
| CancerPDF_ID | CancerPDF_ID1131 |
| PMID | 19470732 |
| Peptide Sequence | NA |
| Peptide Sequence in Publication | NA |
| Protein Name | NA |
| UniprotKB Entry Name | NA |
| Biofluid | Serum |
| M/Z | 5959 |
| Charge | NA |
| Mass/H+ | NA |
| Mass (in Daltons) | NA |
| Profiling Technique | MALDI-TOF |
| Peptide Identification Technique | NA |
| Quantification Technique | ELISA |
| Labeling | Label Free |
| FDR | NA |
| p-Value | less than 0.05 |
| Software | "TagIdent tool from ExPASy Proteomics Server ,ClinProTools" |
| Length of Peptide | NA |
| Cancer Type | Pancreatic cancer |
| Database for Peptide search | SwissProt Database |
| Modification | NA |
| Number of Patients | Pancreatic cancer= 40 and healthy controls = 40 ; for validation patients = 20 and healthy controls = 20 |
| Regulation/Differential Expression | Differentially expressed between cancer vs normal and considered as signature ion |
| Validation | Independent validation |
| Sensitivity | 86.3% on validation dataset |
| Specificity | 97.6% on validation dataset |
| Accuracy | NA |
| Secondary information |
|---|
| Peptide Atlas | NA |
| IEDB | |